Click for best price
MitogenActivated Protein Kinase Inhibitors Market Size, Share 2024
The global Mitogen-Activated Protein Kinase Inhibitors market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Extracellular Signal-Regulated Kinase Signaling Pathway Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Mitogen-Activated Protein Kinase Inhibitors include GEn1E Lifesciences Inc, F. Hoffmann-La Roche Ltd, Lilly, AstraZeneca, Merck & Co., Inc, HepaRegeniX GmbH, GSK plc, Mereo Biopharma Group PLC and Kura Oncology, Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The mitogen-activated protein kinase (MAPK) family is a class of serine/threonine protein kinases that can transduce extracellular signals to the cell and nucleus through a conserved three-level cascade reaction (MAPKKK -MAPKK-MAPK) activates transcription factors that regulate gene expression. This pathway exists in most cells and is related to a variety of cell functions, and can participate in various physiological processes such as cell movement, apoptosis, differentiation, growth and proliferation.
This report aims to provide a comprehensive presentation of the global market for Mitogen-Activated Protein Kinase Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitogen-Activated Protein Kinase Inhibitors. This report contains market size and forecasts of Mitogen-Activated Protein Kinase Inhibitors in global, including the following market information:
Global Mitogen-Activated Protein Kinase Inhibitors Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Mitogen-Activated Protein Kinase Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mitogen-Activated Protein Kinase Inhibitors Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Mitogen-Activated Protein Kinase Inhibitors Market Segment Percentages, by Type, 2023 (%)
Extracellular Signal-Regulated Kinase Signaling Pathway
C-Jun N-Terminal Kinase/Stress-Activated Protein Signaling Pathway
P38 MAPK Signaling Pathway
ERK5/Macromitogen-Activated Protein Kinase Signaling Pathway
Global Mitogen-Activated Protein Kinase Inhibitors Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Mitogen-Activated Protein Kinase Inhibitors Market Segment Percentages, by Application, 2023 (%)
Colon Cancer
Acute Myelogenous Leukemia
Malignant Melanoma
Pancreatic Cancer
Breast Cancer
Other
Global Mitogen-Activated Protein Kinase Inhibitors Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Mitogen-Activated Protein Kinase Inhibitors Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mitogen-Activated Protein Kinase Inhibitors revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Mitogen-Activated Protein Kinase Inhibitors revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
GEn1E Lifesciences Inc
F. Hoffmann-La Roche Ltd
Lilly
AstraZeneca
Merck & Co., Inc
HepaRegeniX GmbH
GSK plc
Mereo Biopharma Group PLC
Kura Oncology, Inc
eFFECTOR Therapeutics, Inc
Selleck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mitogen-Activated Protein Kinase Inhibitors, market overview.
Chapter 2: Global Mitogen-Activated Protein Kinase Inhibitors market size in revenue.
Chapter 3: Detailed analysis of Mitogen-Activated Protein Kinase Inhibitors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mitogen-Activated Protein Kinase Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Mitogen-Activated Protein Kinase Inhibitors Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Mitogen-Activated Protein Kinase Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mitogen-Activated Protein Kinase Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mitogen-Activated Protein Kinase Inhibitors Overall Market Size
2.1 Global Mitogen-Activated Protein Kinase Inhibitors Market Size: 2023 VS 2030
2.2 Global Mitogen-Activated Protein Kinase Inhibitors Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mitogen-Activated Protein Kinase Inhibitors Players in Global Market
3.2 Top Global Mitogen-Activated Protein Kinase Inhibitors Companies Ranked by Revenue
3.3 Global Mitogen-Activated Protein Kinase Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Mitogen-Activated Protein Kinase Inhibitors Companies in Global Market, by Revenue in 2023
3.5 Global Companies Mitogen-Activated Protein Kinase Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mitogen-Activated Protein Kinase Inhibitors Players in Global Market
3.6.1 List of Global Tier 1 Mitogen-Activated Protein Kinase Inhibitors Companies
3.6.2 List of Global Tier 2 and Tier 3 Mitogen-Activated Protein Kinase Inhibitors Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Mitogen-Activated Protein Kinase Inhibitors Market Size Markets, 2023 & 2030
4.1.2 Extracellular Signal-Regulated Kinase Signaling Pathway
4.1.3 C-Jun N-Terminal Kinase/Stress-Activated Protein Signaling Pathway
4.1.4 P38 MAPK Signaling Pathway
4.1.5 ERK5/Macromitogen-Activated Protein Kinase Signaling Pathway
4.2 By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2024
4.2.2 By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2025-2030
4.2.3 By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mitogen-Activated Protein Kinase Inhibitors Market Size, 2023 & 2030
5.1.2 Colon Cancer
5.1.3 Acute Myelogenous Leukemia
5.1.4 Malignant Melanoma
5.1.5 Pancreatic Cancer
5.1.6 Breast Cancer
5.1.7 Other
5.2 By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2024
5.2.2 By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2025-2030
5.2.3 By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Mitogen-Activated Protein Kinase Inhibitors Market Size, 2023 & 2030
6.2 By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2024
6.2.2 By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2025-2030
6.2.3 By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2030
6.3.2 US Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.3.3 Canada Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.3.4 Mexico Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2030
6.4.2 Germany Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4.3 France Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4.4 U.K. Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4.5 Italy Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4.6 Russia Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4.7 Nordic Countries Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.4.8 Benelux Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2030
6.5.2 China Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.5.3 Japan Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.5.4 South Korea Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.5.5 Southeast Asia Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.5.6 India Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2030
6.6.2 Brazil Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.6.3 Argentina Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2030
6.7.2 Turkey Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.7.3 Israel Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.7.4 Saudi Arabia Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
6.7.5 UAE Mitogen-Activated Protein Kinase Inhibitors Market Size, 2019-2030
7 Mitogen-Activated Protein Kinase Inhibitors Companies Profiles
7.1 GEn1E Lifesciences Inc
7.1.1 GEn1E Lifesciences Inc Company Summary
7.1.2 GEn1E Lifesciences Inc Business Overview
7.1.3 GEn1E Lifesciences Inc Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.1.4 GEn1E Lifesciences Inc Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.1.5 GEn1E Lifesciences Inc Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Company Summary
7.2.2 F. Hoffmann-La Roche Ltd Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.2.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.3 Lilly
7.3.1 Lilly Company Summary
7.3.2 Lilly Business Overview
7.3.3 Lilly Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.3.4 Lilly Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.3.5 Lilly Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.4.4 AstraZeneca Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Merck & Co., Inc
7.5.1 Merck & Co., Inc Company Summary
7.5.2 Merck & Co., Inc Business Overview
7.5.3 Merck & Co., Inc Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.5.4 Merck & Co., Inc Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.5.5 Merck & Co., Inc Key News & Latest Developments
7.6 HepaRegeniX GmbH
7.6.1 HepaRegeniX GmbH Company Summary
7.6.2 HepaRegeniX GmbH Business Overview
7.6.3 HepaRegeniX GmbH Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.6.4 HepaRegeniX GmbH Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.6.5 HepaRegeniX GmbH Key News & Latest Developments
7.7 GSK plc
7.7.1 GSK plc Company Summary
7.7.2 GSK plc Business Overview
7.7.3 GSK plc Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.7.4 GSK plc Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.7.5 GSK plc Key News & Latest Developments
7.8 Mereo Biopharma Group PLC
7.8.1 Mereo Biopharma Group PLC Company Summary
7.8.2 Mereo Biopharma Group PLC Business Overview
7.8.3 Mereo Biopharma Group PLC Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.8.4 Mereo Biopharma Group PLC Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.8.5 Mereo Biopharma Group PLC Key News & Latest Developments
7.9 Kura Oncology, Inc
7.9.1 Kura Oncology, Inc Company Summary
7.9.2 Kura Oncology, Inc Business Overview
7.9.3 Kura Oncology, Inc Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.9.4 Kura Oncology, Inc Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.9.5 Kura Oncology, Inc Key News & Latest Developments
7.10 eFFECTOR Therapeutics, Inc
7.10.1 eFFECTOR Therapeutics, Inc Company Summary
7.10.2 eFFECTOR Therapeutics, Inc Business Overview
7.10.3 eFFECTOR Therapeutics, Inc Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.10.4 eFFECTOR Therapeutics, Inc Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.10.5 eFFECTOR Therapeutics, Inc Key News & Latest Developments
7.11 Selleck
7.11.1 Selleck Company Summary
7.11.2 Selleck Business Overview
7.11.3 Selleck Mitogen-Activated Protein Kinase Inhibitors Major Product Offerings
7.11.4 Selleck Mitogen-Activated Protein Kinase Inhibitors Revenue in Global Market (2019-2024)
7.11.5 Selleck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Mitogen-Activated Protein Kinase Inhibitors Market Opportunities & Trends in Global Market
Table 2. Mitogen-Activated Protein Kinase Inhibitors Market Drivers in Global Market
Table 3. Mitogen-Activated Protein Kinase Inhibitors Market Restraints in Global Market
Table 4. Key Players of Mitogen-Activated Protein Kinase Inhibitors in Global Market
Table 5. Top Mitogen-Activated Protein Kinase Inhibitors Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Mitogen-Activated Protein Kinase Inhibitors Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Mitogen-Activated Protein Kinase Inhibitors Revenue Share by Companies, 2019-2024
Table 8. Global Companies Mitogen-Activated Protein Kinase Inhibitors Product Type
Table 9. List of Global Tier 1 Mitogen-Activated Protein Kinase Inhibitors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mitogen-Activated Protein Kinase Inhibitors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Mitogen-Activated Protein Kinase Inhibitors Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Mitogen-Activated Protein Kinase Inhibitors Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Mitogen-Activated Protein Kinase Inhibitors Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Mitogen-Activated Protein Kinase Inhibitors Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2025-2030
Table 30. GEn1E Lifesciences Inc Company Summary
Table 31. GEn1E Lifesciences Inc Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 32. GEn1E Lifesciences Inc Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 33. GEn1E Lifesciences Inc Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Ltd Company Summary
Table 35. F. Hoffmann-La Roche Ltd Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 36. F. Hoffmann-La Roche Ltd Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 37. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 38. Lilly Company Summary
Table 39. Lilly Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 40. Lilly Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 41. Lilly Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 44. AstraZeneca Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Merck & Co., Inc Company Summary
Table 47. Merck & Co., Inc Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 48. Merck & Co., Inc Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 49. Merck & Co., Inc Key News & Latest Developments
Table 50. HepaRegeniX GmbH Company Summary
Table 51. HepaRegeniX GmbH Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 52. HepaRegeniX GmbH Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 53. HepaRegeniX GmbH Key News & Latest Developments
Table 54. GSK plc Company Summary
Table 55. GSK plc Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 56. GSK plc Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 57. GSK plc Key News & Latest Developments
Table 58. Mereo Biopharma Group PLC Company Summary
Table 59. Mereo Biopharma Group PLC Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 60. Mereo Biopharma Group PLC Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 61. Mereo Biopharma Group PLC Key News & Latest Developments
Table 62. Kura Oncology, Inc Company Summary
Table 63. Kura Oncology, Inc Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 64. Kura Oncology, Inc Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 65. Kura Oncology, Inc Key News & Latest Developments
Table 66. eFFECTOR Therapeutics, Inc Company Summary
Table 67. eFFECTOR Therapeutics, Inc Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 68. eFFECTOR Therapeutics, Inc Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 69. eFFECTOR Therapeutics, Inc Key News & Latest Developments
Table 70. Selleck Company Summary
Table 71. Selleck Mitogen-Activated Protein Kinase Inhibitors Product Offerings
Table 72. Selleck Mitogen-Activated Protein Kinase Inhibitors Revenue (US$, Mn) & (2019-2024)
Table 73. Selleck Key News & Latest Developments
List of Figures
Figure 1. Mitogen-Activated Protein Kinase Inhibitors Segment by Type in 2023
Figure 2. Mitogen-Activated Protein Kinase Inhibitors Segment by Application in 2023
Figure 3. Global Mitogen-Activated Protein Kinase Inhibitors Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Mitogen-Activated Protein Kinase Inhibitors Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Mitogen-Activated Protein Kinase Inhibitors Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mitogen-Activated Protein Kinase Inhibitors Revenue in 2023
Figure 8. By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 9. By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 10. By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 12. By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 14. By Region - Global Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 15. By Country - North America Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 16. US Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 20. Germany Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 21. France Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 28. China Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 32. India Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 34. Brazil Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Mitogen-Activated Protein Kinase Inhibitors Revenue Market Share, 2019-2030
Figure 37. Turkey Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Mitogen-Activated Protein Kinase Inhibitors Revenue, (US$, Mn), 2019-2030
Figure 41. GEn1E Lifesciences Inc Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. F. Hoffmann-La Roche Ltd Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Lilly Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. AstraZeneca Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Merck & Co., Inc Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. HepaRegeniX GmbH Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. GSK plc Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Mereo Biopharma Group PLC Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Kura Oncology, Inc Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. eFFECTOR Therapeutics, Inc Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Selleck Mitogen-Activated Protein Kinase Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
